Trial intelligence / Profile preview

SPRIX (intranasal ketorolac tromethamine) in pediatric patients undergoing open surgery

2013-003310-40Phase 3Completed

Sponsor
Luitpold Pharmaceuticals
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of ketorolac in postoperative pain, sponsored by Luitpold Pharmaceuticals. Primary endpoint: Safety and pharmacokinetics. Started Nov 2013; status: completed.

02

Drugs

ketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2013-003310-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003310-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call